Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer
| Image |  |
|---|---|
| Description | scientific article published on 14 October 2019 |
| Author/s |
author: James Chih-Hsin Yang |
| Publication date | October 14, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |